Search for other papers by Yuan Fang in
Google Scholar
PubMed
Search for other papers by Xuehong Zhang in
Google Scholar
PubMed
Search for other papers by Huilin Xu in
Google Scholar
PubMed
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
Search for other papers by Stephanie A Smith-Warner in
Google Scholar
PubMed
Search for other papers by Dongli Xu in
Google Scholar
PubMed
Search for other papers by Hong Fang in
Google Scholar
PubMed
Search for other papers by Wang Hong Xu in
Google Scholar
PubMed
retrospective cohort study based on a standardized T2DM management system in Shanghai, China, we estimated the risk of cancer, overall and by site, by the time since diagnoses in Chinese patients newly diagnosed with T2DM, to evaluate the influence of T2DM on
Search for other papers by Zhou Zheng in
Google Scholar
PubMed
Search for other papers by Xiuming Zhang in
Google Scholar
PubMed
Search for other papers by Fanggui Wu in
Google Scholar
PubMed
Search for other papers by Haizhen Liao in
Google Scholar
PubMed
Search for other papers by Huan Zhao in
Google Scholar
PubMed
Search for other papers by Minqi Zhang in
Google Scholar
PubMed
Search for other papers by Shangjie Liu in
Google Scholar
PubMed
stimulation protocol in women who received the GnRH agonist long-acting protocol or the GnRH antagonist protocol: a retrospective cohort study . Frontiers in Endocrinology 2022 13 899000 . ( https://doi.org/10.3389/fendo.2022.899000 ) 29 Adebayo FO Ameh
Search for other papers by Lei Gao in
Google Scholar
PubMed
Search for other papers by Wenxia Cui in
Google Scholar
PubMed
Search for other papers by Dinghuang Mu in
Google Scholar
PubMed
Search for other papers by Shaoping Li in
Google Scholar
PubMed
Search for other papers by Nan Li in
Google Scholar
PubMed
Search for other papers by Weihong Zhou in
Google Scholar
PubMed
Search for other papers by Yun Hu in
Google Scholar
PubMed
prevalence of MASLD in the world is greater than 30% ( 2 ). MASLD is a multi-systemic disease affecting not only the liver but also extra-hepatic organs ( 3 ). A study conducted on a nationwide cohort found that patients with MASLD have a higher likelihood of
Search for other papers by Hiren Patt in
Google Scholar
PubMed
Search for other papers by Katrin Koehler in
Google Scholar
PubMed
Search for other papers by Sailesh Lodha in
Google Scholar
PubMed
Search for other papers by Swati Jadhav in
Google Scholar
PubMed
Search for other papers by Chaitanya Yerawar in
Google Scholar
PubMed
Search for other papers by Angela Huebner in
Google Scholar
PubMed
Search for other papers by Kunal Thakkar in
Google Scholar
PubMed
Search for other papers by Sneha Arya in
Google Scholar
PubMed
Search for other papers by Sandhya Nair in
Google Scholar
PubMed
Search for other papers by Manjunath Goroshi in
Google Scholar
PubMed
Search for other papers by Hosahithlu Ganesh in
Google Scholar
PubMed
Search for other papers by Vijaya Sarathi in
Google Scholar
PubMed
Search for other papers by Anurag Lila in
Google Scholar
PubMed
Search for other papers by Tushar Bandgar in
Google Scholar
PubMed
Search for other papers by Nalini Shah in
Google Scholar
PubMed
methods Cohort 1 A retrospective clinical case records study of TAS patients (cohort 1) managed at a tertiary care center (2004–2016) in Western India was conducted after obtaining approval from ‘Institutional Ethics Committee II, Seth G S Medical
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Jes Sloth Mathiesen in
Google Scholar
PubMed
Search for other papers by Jens Peter Kroustrup in
Google Scholar
PubMed
Steno Diabetes Center North Jutland, Aalborg, Denmark
Search for other papers by Peter Vestergaard in
Google Scholar
PubMed
Search for other papers by Per Løgstrup Poulsen in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Sten Schytte in
Google Scholar
PubMed
Search for other papers by Stefano Christian Londero in
Google Scholar
PubMed
Search for other papers by Henrik Baymler Pedersen in
Google Scholar
PubMed
Search for other papers by Christoffer Holst Hahn in
Google Scholar
PubMed
Search for other papers by Jens Bentzen in
Google Scholar
PubMed
Odense Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark
Search for other papers by Sören Möller in
Google Scholar
PubMed
Search for other papers by Mette Gaustadnes in
Google Scholar
PubMed
Search for other papers by Maria Rossing in
Google Scholar
PubMed
Search for other papers by Finn Cilius Nielsen in
Google Scholar
PubMed
Search for other papers by Kim Brixen in
Google Scholar
PubMed
Search for other papers by Christian Godballe in
Google Scholar
PubMed
Search for other papers by Danish Thyroid Cancer Group (DATHYRCA) in
Google Scholar
PubMed
. Patients and methods Patients This retrospective cohort study included 191 unique patients diagnosed with MTC in Denmark between January 1, 1997, and December 31, 2014. An MTC cohort, initially comprising 476 patients diagnosed with MTC in Denmark
Search for other papers by Giuseppe Lisco in
Google Scholar
PubMed
Search for other papers by Anna De Tullio in
Google Scholar
PubMed
Search for other papers by Olga Disoteo in
Google Scholar
PubMed
Search for other papers by Giuseppina Piazzolla in
Google Scholar
PubMed
Search for other papers by Edoardo Guastamacchia in
Google Scholar
PubMed
Search for other papers by Carlo Sabbà in
Google Scholar
PubMed
Search for other papers by Vincenzo De Geronimo in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
Search for other papers by Vincenzo Triggiani in
Google Scholar
PubMed
information. Around 48,000 people (47,746) with established diagnoses of T2D and who were on ‘second-line’ treatment between 2006 and 2018 were included in the retrospective cohort. The cases of thyroid cancer were identified after the consultation of hospital
Search for other papers by Sara Ahmadi in
Google Scholar
PubMed
Search for other papers by Alexandra Coleman in
Google Scholar
PubMed
Endocrinology Service, Instituto Nacional de Câncer, Rio de Janeiro, Brazil
Search for other papers by Nathalie Silva de Morais in
Google Scholar
PubMed
Search for other papers by Iñigo Landa in
Google Scholar
PubMed
Search for other papers by Theodora Pappa in
Google Scholar
PubMed
Search for other papers by Alex Kang in
Google Scholar
PubMed
Search for other papers by Matthew I Kim in
Google Scholar
PubMed
Search for other papers by Ellen Marqusee in
Google Scholar
PubMed
Search for other papers by Erik K Alexander in
Google Scholar
PubMed
this study. First, we note that this is a retrospective cohort assessment. However, the two cohorts nonetheless appear logically separated by time as SPECT-CT was implemented. We separately acknowledge that the use of I-131 for thyroid cancer during
Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Search for other papers by Johan Botling in
Google Scholar
PubMed
Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Search for other papers by Barbro Eriksson in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Search for other papers by Anders Sundin in
Google Scholar
PubMed
Search for other papers by Joakim Crona in
Google Scholar
PubMed
Epidemiology Guidelines ( 18 ). Study design, setting and participants This was a single-center retrospective cohort study at Uppsala University Hospital, Uppsala, Sweden. Patients were included when they fulfilled the following criteria: (i
Search for other papers by Ruth Therese Casey in
Google Scholar
PubMed
Search for other papers by Deborah Saunders in
Google Scholar
PubMed
Search for other papers by Benjamin George Challis in
Google Scholar
PubMed
Search for other papers by Deborah Pitfield in
Google Scholar
PubMed
Search for other papers by Heok Cheow in
Google Scholar
PubMed
Search for other papers by Ashley Shaw in
Google Scholar
PubMed
Search for other papers by Helen Lisa Simpson in
Google Scholar
PubMed
mean ED identified in this cohort and the lack of secondary tumour induction, may be accounted for by the relatively short review period of this study (8 years). We recognise the limitations of this study that include retrospective design, short study
Search for other papers by Chao-bin He in
Google Scholar
PubMed
Search for other papers by Yu Zhang in
Google Scholar
PubMed
Search for other papers by Zhi-yuan Cai in
Google Scholar
PubMed
Search for other papers by Xiao-jun Lin in
Google Scholar
PubMed
. Materials and methods Patients Patients diagnosed with metastatic PNET from 2004 to 2015 were retrospectively collected from the SEER database in this study. Inclusion criteria based on International Classification of Diseases for Oncology were as